Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04302948 · ClinicalTrials.gov registry record · NA
Rapid HCV RNA Testing and LInkage to Care
A NA study, sponsored by University of New Mexico.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT04302948 is a NA study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 31 participants.
The verdict
NCT04302948, a NA study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The investigators propose to conduct a pilot randomized controlled trial comparing treatment as usual (TaU) for HCV screening (rapid anti-HCV screening and referral) to a intervention screening that includes TaU plus a rapid point-of-care HCV RNA test in persons experiencing homelessness. The primary outcome of interest is linkage-to-care. Linkage to care is defined as evaluation by a health care provider for HCV infection within 30 days of baseline screening and referral. We will compare the proportion of patients who are evaluated by a provider within the 30 day window in each study arm: (1) participants who screened positive with rapid anti-HCV and are referred for evaluation) and (2) Rapid HCV RNA plus TaU (those who tested positive with both rapid anti-HCV and confirmatory RNA and are also referred to a provider.) Secondarily, the investigators will also assess HCV RNA levels in both groups twelve weeks after treatment ends (24 to 36 weeks after anti-HCV screening) to determine the percent of individuals who achieved sustained virologic response (SVR12), which is a marker for cure.
Interventions
- OTHER HCV RNA screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-03-02 |
| Est. Completion | 2020-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04302948
The ClinicalTrials.gov registry entry for NCT04302948 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HCV RNA screening is the first listed.
NCT04302948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04302948 about?
NCT04302948 is a clinical study titled "Rapid HCV RNA Testing and LInkage to Care". The investigators propose to conduct a pilot randomized controlled trial comparing treatment as usual (TaU) for HCV screening (rapid anti-HCV screening and referral) to a intervention screening that includes TaU plus a rapid point-of-care HCV RNA test in persons experiencing homelessness. The primar...
What is the current status of trial NCT04302948?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2020-03-02. Estimated completion is 2020-04-01.
What interventions are being tested in trial NCT04302948?
The interventions under investigation include: HCV RNA screening (OTHER).
Who is sponsoring clinical trial NCT04302948?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.